Anti-NMDA receptor encephalitis risk factors: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Anti-NMDA receptor encephalitis}} {{CMG}} ==Overview== ==Risk Factors== ==References== {{Reflist|2}} Category:Needs content Category:Rheumatology Cate...") |
No edit summary |
||
Line 6: | Line 6: | ||
==Risk Factors== | ==Risk Factors== | ||
The risk factors include females preponderance, the high incidence of the disease in youngsters, and the increased likelihood of an underlying teratoma among African-Americans. Asian patients had a higher incidence of teratomas. | |||
==References== | ==References== |
Revision as of 12:41, 11 February 2023
Anti-NMDA receptor encephalitis Microchapters |
Differentiating Anti-NMDA receptor encephalitis from Other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Anti-NMDA receptor encephalitis risk factors On the Web |
American Roentgen Ray Society Images of Anti-NMDA receptor encephalitis risk factors |
Directions to Hospitals Treating Anti-NMDA receptor encephalitis |
Risk calculators and risk factors for Anti-NMDA receptor encephalitis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Risk Factors
The risk factors include females preponderance, the high incidence of the disease in youngsters, and the increased likelihood of an underlying teratoma among African-Americans. Asian patients had a higher incidence of teratomas.